Substance Abuse, Intravenous

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Substance Abuse, Intravenous trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT05679284

A Cross-Sectional Observational Study on Retained Drug Needle Fragments in People Who Use Intravenous Drugs

In addition to the well-known toxicological harms of intravenous drug (IVD) use, there can also be local tissue complications, including infections, venous scle…

Finland100 participantsStarted 2023-05-25

Treatment: Low-dose X-ray of subcutaneous tissues

All recent trials (48 shown)

Active — Not RecruitingNot Applicable

NCT05657106

Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk

This study will test the effectiveness, implementation outcomes, and cost effectiveness of a community-tailored, harm reduction kiosk in reducing HIV, hepatitis…

United States752 participantsStarted 2023-03-06

Treatment: Harm reduction kiosk

Active — Not RecruitingNot Applicable

NCT05360849

Implementing PrEP for Women Who Inject Drugs

Women who inject drugs are among the most vulnerable to acquiring HIV, but very few women who inject drugs are prescribed pre-exposure prophylaxis (PrEP) for HI…

United States130 participantsStarted 2021-06-22

Treatment: Practice Facilitation

Substance Abuse, Intravenous

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Cross-Sectional Observational Study on Retained Drug Needle Fragments in People Who Use Intravenous Drugs

All recent trials (48 shown)

Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk

Implementing PrEP for Women Who Inject Drugs

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Cross-Sectional Observational Study on Retained Drug Needle Fragments in People Who Use Intravenous Drugs

All recent trials (48 shown)

Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk

Implementing PrEP for Women Who Inject Drugs

A Clinical Study to Evaluate the Safety of CS-1103 in Healthy Participants

Histiocytosis in Injecting Drug Users

Break the Cycle: Prevention for Reducing Initiation Into Injection Drug Use

Crossover Study to Evaluate the Abuse Potential of Intranasal Esketamine Compared to Racemic Intravenous Ketamine in Non…

Telemedicine and Social Media for People Who Inject Drugs (PWID) in Greece

Clavulanic Acid (CLAV) and Cocaine Interaction Safety Study

Substance Use Disorder (SUD)-Associated Infections' Treatment With Dalbavancin ENabling OUtpatient Transition

Non-Invasive Vagal Nerve Stimulation in Opioid Use Disorders

Change the Cycle: An RCT to Prevent Injection Initiation

The Long-Term Treatment of Drug Addiction and Unemployment

BRIDGE: Improving HIV Service Delivery for People Who Inject Drugs

PWID; Longitudinal S Aureus Colonization Pattern and the Impact on Infection Frequency by Regular Showers With Chlorhexi…

Stage III Community-based Efficacy Trial for Mothering From the Inside Out

Pre-exposure Prophylaxis (PrEP) for People Who Inject Drugs (PWID)

Hepatitis C Treatment in PWIDs: MAT or Syringe Exchange Assisted-therapy vs Standard of Care

: Bacterial Infections in Injecting Drug Users

Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1

Case Management in HCV Infected PWID